|
||||||||||||||||||||||
General Assembly Invitation
|
||||||||||||||||||||||
|
||||||||||||||||||||||
Agenda Items
|
||||||||||||||||||||||
1 - Opening, establishment of the meeting chairmanship and a moment of silence
|
||||||||||||||||||||||
2 - Authorizing the meeting chairman to sign the minutes and other documents of the general assembly meeting,
|
||||||||||||||||||||||
3 - Reading and discussing the "Board of Directors Annual Report" for the fiscal year 2023 and submitting it for approval
|
||||||||||||||||||||||
4 - Reading the "Independent Audit Report" for the fiscal year 2023
|
||||||||||||||||||||||
5 - Reading, discussing and submitting for approval the 2023 Financial Report, Profit Loss accounts for the fiscal year 2023
|
||||||||||||||||||||||
6 - Discussing and deciding on the release of the members of the Board of Directors for the fiscal year 2023
|
||||||||||||||||||||||
7 - Discussing and decision on the Board of Directors' proposal regarding distribution of the dividend and the date of dividend to fiscal year 2023
|
||||||||||||||||||||||
8 - Election of Independent Members of the Board of Directors and determination of their terms of office in accordance with the provisions of the relevant legislation
|
||||||||||||||||||||||
9 - Determining the remuneration of the members of the Board of Directors
|
||||||||||||||||||||||
10 - Submission to Voting and Resolving for Granting Authority to the Members of the Board of Directors in Accordance with Article 395 and Article 396 of the Turkish Commercial Code
|
||||||||||||||||||||||
11 - Discussing and deciding on the proposal of the Board of Directors regarding the selection of an External Auditor for Auditing of Company's Accounts and Transactions for 2024 in accordance with the Turkish Commercial Law and the Capital Markets Law
|
||||||||||||||||||||||
12 - Informing the General Assembly on Guarantee, Pledge and Mortgages Granted in Favor of the Third Parties and of Any Benefits or Income thereof
|
||||||||||||||||||||||
13 - Providing information about the grants and donations made in 2023, submission of the grants and donations made in 2024 for approval and deciding on the donation limit for the fiscal period 01.01.2024- 31.12.2024
|
||||||||||||||||||||||
14 - Discussion and approval of the Board of Directors Decision No. 2023/22 regarding the possibility of allocating venture capital funds
|
||||||||||||||||||||||
15 - Closing
|
||||||||||||||||||||||
Corporate Actions Involved In Agenda
|
||||||||||||||||||||||
|
||||||||||||||||||||||
General Assembly Results
|
||||||||||||||||||||||
|
||||||||||||||||||||||
Decisions Regarding Corporate Actions
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
||||||||||||||||||||||
Additional Explanations
|
||||||||||||||||||||||
|
We proclaim that our above disclosure is in conformity with the principles set down in “Material Events Communiqué” of Capital Markets Board, and it fully reflects all information coming to our knowledge on the subject matter thereof, and it is in conformity with our books, records and documents, and all reasonable efforts have been shown by our Company in order to obtain all information fully and accurately about the subject matter thereof, and we’re personally liable for the disclosures.